IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
Chapter-by-chapter discussion, covering:
Find more by Thomas Hager here: https://www.thomashager.net
Dr. Jeremy M. Levin is Chairman and CEO of Ovid Therapeutics Inc (NASDAQ:OVID), a company whose mission is to bring treatment to patients with rare neurological conditions. Dr. Levin is concurrently …
The books Annie recommends:
Maria Konnikova
The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win
Philip Tetlock, Dan Gardner
Superforecasting: The Art and Science of Prediction
Don …
Peter on Twitter: https://twitter.com/peterkolchinsky
The book's website: https://peterkolchinsky.com/bio
Link to the Katherine Eban discussion:
For more on JLABS, go to https://jlabs.jnjinnovation.com/JLABSNavigator#/
As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Compani…
Links to the papers we discuss
IDEA Pharma: IDEA Collider Jackie Hunter
https://www.youtube.com/watch?v=K59qefVIsbA
Interviewer: So welcome to another series of IDEA Collider with leaders in innovation. I'm delighted to be joine…
0:00 Defining innovation
01:00 Incremental innovation vs big changes
01:45 On designing back from the unmet need, and introducing innovation
(Interruption by a phone call �)
02:54 Problem backwards vs so…
IDEA Pharma: IDEA Collider Mike Rea talks with Joseph Owens from Google X
Joseph Owens: Good to see you.
Mike Rea: Thanks for coming over. So, this is just for the benef…
00:20 Introduction: what does Silicon Valley Bank's Life Sciences and Healthcare group do?
01:00 Nooman's background
01:30 How does SVB fit into the innovation ecosystem?
02:00 Lending to companies who …
https://www.youtube.com/watch?v=AgUJQtQUrEs
IDEA Pharma: A Conversation with Dr. Menelas Pangalos of AstraZeneca
Mike Rea: Just a quick note this is Menelas Pangalos, can I h…
John Carroll can be found at:
@johncendpts on Twitter or
www.endpts.com
Opens with intro of Safi Bahcall
Discussion of leadership of innovation
S and P innovation
Pharmaceutical examples
Culture vs incentives
Serendipity and prediction